MIAMI, June 02, 2017 (GLOBE NEWSWIRE) -- Veru Healthcare (NASDAQ:FHCO), a pharmaceuticals company focused on developing pharmaceuticals for men’s and women’s health and oncology, today announced that Mitchell Steiner, M.D., Chief Executive Officer, will present at the 7th Annual LD Micro Invitational on Wednesday, June 7, 2017, at 12:30 pm Pacific Time. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.
The investor presentation to be used at the conference will be posted to the Investors section of the Company's website at www.veruhealthcare.com at approximately 12:00 pm Pacific Time on Wednesday, June 7th.
Management will be available for one-on-one meetings on both Tuesday, June 6th and Wednesday, June 7th. To schedule a meeting, please contact your LD Micro representative or Chris Lahiji at email@example.com.
About Veru Healthcare
Veru Healthcare is a pharmaceutical company, with a focus on the development and commercialization of pharmaceuticals that qualify for FDA's 505(b)(2) accelerated regulatory approval pathway as well as the 505(b)(1) pathway. The Company does business and is organized as follows:
- Veru Healthcare manages the Pharmaceuticals Division, which develops and commercializes pharmaceutical products for men's and women's health and oncology.
- Veru Healthcare manages the Consumer Health / Medical Devices Division, which is focused on commercializing sexual healthcare products and devices for the consumer market, including the Company's FC2 Female Condom® (now available by prescription) and PREBOOST® medicated individual wipe, which is a male genital desensitizing drug product that helps in the prevention of premature ejaculation.
- The Female Health Company division of Veru Healthcare manages the Global Public Health Division, which is focused on the global public health sector FC2 business. This division markets the Company’s Female Condom (FC2) to entities, including ministries of health, government health agencies, U.N. agencies, nonprofit organizations and commercial partners, that work to support and improve the lives, health and well-being of women around the world.
More information about the Company and its products can be found at www.PREBOOST.com and www.fc2femalecondom.com. For corporate and investor-related information about the Company, please visit https://veruhealthcare.com/investors.
Contact: Institutional / Retail Investors: Matthew Beck The Trout Group LLC 646-378-2933 firstname.lastname@example.org Kevin Gilbert Veru Healthcare 312-366-2633 email@example.com